α-Tocopherol binding to human serum albumin

BioFactors

Volumn 39, Issue 3, 2013, Pages 294-303

  Fanali, Gabriella ^a   Fasano, Mauro ^a   Ascenzi, Paolo ^b,c   Zingg, Jean Marc ^d   Azzi, Angelo ^d  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b ROMA TRE UNIVERSITY   (Italy)

^c NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

^d TUFTS UNIVERSITY   (United States)

Author keywords

tocopherol; Binding mode; FA3 FA4 cleft; Human serum albumin; Thermodynamics

Indexed keywords

ABC TRANSPORTER A1; ALPHA TOCOPHEROL; CARRIER PROTEIN; SERUM ALBUMIN;

ALLOSTERISM; ARTICLE; BINDING KINETICS; BINDING SITE; CONTROLLED STUDY; HUMAN; PRIORITY JOURNAL;

ALPHA-TOCOPHEROL; CARRIER PROTEINS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; PROTEIN BINDING; SERUM ALBUMIN; THERMODYNAMICS; WARFARIN;

EID: 84879410126     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.1070     Document Type: Article

References (57)

1. Peters, T., Jr. (1996) All About Albumin: Biochemistry, Genetics and Medical Applications. Academic Press, San Diego, CA.
2. Kragh-Hansen, U., Chuang, V. T., and Otagiri, M. (2002) Practical aspects of the ligand-binding and enzymatic properties of human serum albumin. Biol. Pharm. Bull. 25, 695-704.
3. Ghuman, J., Zunszain, P. A., Petitpas, I., Bhattacharya, A. A., Otagiri, M., et al. (2005) Structural basis of the drug-binding specificity of human serum albumin. J. Mol. Biol. 353, 38-52.
4. Curry, S. (2009) Lessons from the crystallographic analysis of small molecule binding to human serum albumin. Drug Metab. Pharmacokinet. 24, 342-357.
5. Ascenzi, P. and Fasano, M. (2010) Allostery in a monomeric protein: the case of human serum albumin. Biophys. Chem. 148, 16-22.
6. Varshney, A., Sen, P., Ahmad, E., Rehan, M., Subbarao, N., et al. (2010) Ligand binding strategies of human serum albumin: how can the cargo be utilized? Chirality 22, 77-87.
7. Fanali, G., di Masi, A., Trezza, V., Marino, M., Fasano, M., et al. (2012) Human serum albumin: from bench to bedside. Mol. Aspects Med. 33, 209-908.
8. Noel, E. S., Reis, M. D., Arain, Z., and Ober, E. A. (2010) Analysis of the Albumin/α-Fetoprotein/Afamin/Group specific component gene family in the context of zebrafish liver differentiation. Gene Expr. Patterns 10, 237-243.
9. Bhattacharya, A. A., Grüne, T., and Curry, S. (2000) Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. J. Mol. Biol. 303, 721-732.
10. van der Vusse, G. J. (2009) Albumin as fatty acid transporter. Drug Metab. Pharmacokinet. 24, 300-307.
11. Fasano, M., Fanali, G., Leboffe, L., and Ascenzi, P. (2007) Heme binding to albuminoid proteins is the result of recent evolution. IUBMB Life 59, 436-440.
12. Petitpas, I., Petersen, C. E., Ha, C. E., Bhattacharya, A. A., Zunszain, P. A., et al. (2003) Structural basis of albumin-thyroxine interactions and familial dysalbuminemic hyperthyroxinemia. Proc. Natl. Acad. Sci. USA 100, 6440-6445.
13. Lejon, S., Cramer, J. F., and Nordberg, P. (2008) Structural basis for the binding of naproxen to human serum albumin in the presence of fatty acids and the GA module. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 64, 64-69.
14. Himmelfarb, J., Kane, J., McMonagle, E., Zaltas, E., Bobzin, S., et al. (2003) Alpha and gamma tocopherol metabolism in healthy subjects and patients with end-stage renal disease. Kidney Int. 64, 978-991.
15. Zhang, W. X., Thakur, V., Lomize, A., Pogozheva, I., Panagabko, C., et al. (2011) The contribution of surface residues to membrane binding and ligand transfer by the α-tocopherol transfer protein (α-TTP). J. Mol. Biol. 405, 972-988.
16. Voegele, A. F., Jerkovic, L., Wellenzohn, B., Eller, P., Kronenberg, F., et al. (2002) Characterization of the vitamin E-binding properties of human plasma afamin. Biochemistry 41, 14532-14538.
17. Jerkovic, L., Voegele, A. F., Chwatal, S., Jerkovic, L., Voegele, A. F., et al. (2005) Afamin is a novel human vitamin E-binding glycoprotein characterization and in vitro expression. J. Proteome Res. 4, 889-899.
18. Stocker, A. (2004) Molecular mechanisms of vitamin E transport. Ann. N. Y. Acad. Sci. 1031, 44-59.
19. Rigotti, A. (2007) Absorption, transport, and tissue delivery of vitamin E. Mol. Aspects Med. 28, 423-436.
20. Clarke, M. W., Burnett, J. R., and Croft, K. D. (2008) Vitamin E in human health and disease. Crit. Rev. Clin. Lab. Sci. 45, 417-450.
21. Kayden, H. J. and Traber, M. G. (1993) Abetalipoproteinemia and homozygous hypobetalipoproteinemia. In Primary Hyperlipidemias (Steiner, G. and Shafrir, E., eds.). pp. 249-260, McGraw-Hill, New York.
22. Desrumaux, C., Deckert, V., Athias, A., Masson, D., Lizard, G., et al. (2009) Plasma phospholipid transfer protein prevents vascular endothelium dysfunction by delivering α-tocopherol to endothelial cells. FASEB J. 13, 883-892.
23. Fanali, G., Pariani, G., Ascenzi P., and Fasano, M. (2009) Allosteric and binding properties of Asp1-Glu382 truncated recombinant human serum albumin: an optical and NMR spectroscopic investigation. FEBS J. 276, 2241-2250.
24. Chen, R. F. (1967) Removal of fatty acids from serum albumin by charcoal treatment. J. Biol. Chem. 242, 173-181.
25. Sogami, M. and Foster, J. F. (1968) Isomerization reactions of charcoal-defatted bovine plasma albumin. The N-F transition and acid expansion. Biochemistry 7, 2172-2182.
26. Cabrera-Crespo, J., Goncalves, V. M., Martins, E. A., Grellet, S., Lopes, A. P., et al. (2000) Albumin purification from human placenta. Biotechnol. Appl. Biochem. 31, 101-106.
27. Sudlow, G., Birkett, D. J., and Wade, D. N. (1975) The characterization of two specific drug binding sites on human serum albumin. Mol. Pharmacol. 11, 824-832.
28. Nakajou, K., Watanabe, H., Kragh-Hansen, U., Maruyama, T., and Otagiri, M. (2003) The effect of glycation on the structure, function and biological fate of human serum albumin as revealed by recombinant mutants. Biochim. Biophys. Acta 1623, 88-97.
29. Fanali, G., Fesce, R., Agrati, C., Ascenzi, P., and Fasano, M. (2005) Allosteric modulation of myristate and Mn(III)heme binding to human serum albumin: optical and NMR spectroscopy characterization. FEBS J. 272, 4672-4683.
30. Simard, J. R., Zunszain, P. A., Hamilton, J. A., and Curry, S. (2006) Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis. J. Mol. Biol. 361, 336-351.
31. Fanali, G., Cao, Y., Ascenzi, P., Trezza, V., Rubino, T., et al. (2011) Binding of δ9-tetrahydrocannabinol and diazepam to human serum albumin. IUBMB Life 63, 446-451.
32. Boffi, A., Das, T. K., Della Longa, S., Spagnuolo, C., and Rousseau, D. L. (1999) Pentacoordinate hemin derivatives in sodium dodecyl sulfate micelles: model systems for the assignment of the fifth ligand in ferric heme proteins. Biophys. J. 77, 1143-1149.
33. Fanali, G., Bocedi, A., Ascenzi, P., and Fasano, M. (2007) Modulation of heme and myristate binding to human serum albumin by anti-HIV drugs: an optical and NMR spectroscopic study. FEBS J. 274, 4491-4502.
34. Sudlow, G., Birkett, D. J., and Wade, D. N. (1976) Further characterization of specific drug binding sites on human serum albumin. Mol. Pharmacol. 12, 1052-1061.
35. i and presentation of data in comparative studies. Biochem. Mol. Biol. Educ. 15, 134-135.
36. Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., et al. (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. Comput. Chem. 30, 2785-2791.
37. Sugio, S., Kashima, A., Mochizuki, S., Noda, M., and Kobayashi, K. (1999) Crystal structure of human serum albumin at 2.5 Å resolution. Protein Eng. 12, 439-446.
38. 2 from Bothrops genus reveal their myotoxic site. J. Struct. Biol. 167, 106-116.
39. Zunszain, P. A., Ghuman, J., Komatsu, T., Tsuchida, E., and Curry, S, (2003) Crystal structural analysis of human serum albumin complexed with hemin and fatty acid. BMC Struct. Biol. 3, 6.
40. Ryan, A. J., Ghuman, J., Zunszain, P. A., Chung, C. W., and Curry, S. (2011) Structural basis of binding of fluorescent, site-specific dansylated amino acids to human serum albumin. J. Struct. Biol. 174, 84-91.
41. Upadhyay, J. and Misra, K. (2009) Towards the interaction mechanism of tocopherols and tocotrienols (vitamin E) with selected metabolizing enzymes. Bioinformation 3, 326-331.
42. Panagabko, C., Morley, S., Hernandez, M., Cassolato, P., Gordon, H., et al. (2003) Ligand specificity in the CRAL-TRIO protein family. Biochemistry 42, 6467-6474.
43. Bocedi, A., Notari, S., Menegatti, E., Fanali, G., Fasano, M., et al. (2005) Allosteric modulation of anti-HIV drug and ferric heme binding to human serum albumin. FEBS J. 272, 6287-6296.
44. Bolli, A., Marino, M., Rimbach, G., Fanali, G., Fasano, M., et al. (2010) Flavonoid binding to human serum albumin. Biochem. Biophys. Res. Commun. 398, 444-449.
45. Kamińnska, J., Sobiak, J., Glyda, M., Duda, G., Nogala-Kalucka, M., et al. (2012) Effect of clinical condition and mycophenolate mofetil on plasma retinol, α-tocopherol and β-carotene in renal transplant recipients. Arch. Med. Sci. 8, 256-262.
46. Behrens, W. A., Thompson, J. N., and Madère, R. (1982) Distribution of α-tocopherol in human plasma lipoproteins. Am. J. Clin. Nutr. 35, 691-696.
47. Carr, T. P., Traber, M. G., Haines, J. L., Kayden, H. J., Parks, J. S., et al. (1993) Interrelationships of α-tocopherol with plasma lipoproteins: effects of dietary fats in African green monkeys. J. Lipid Res. 34, 1863-1871.
48. Kayden, H. J. and Traber, M. G. (1993) Absorption, lipoprotein transport, and regulation of plasma concentrations of vitamin E in humans. J. Lipid Res. 34, 343-358.
49. Traber, M. G., Rader, D., Acuff, R., Brewer, H. B., and Kayden, H. J. (1994) Discrimination between RRR- and all rac-α-tocopherols labeled with deuterium by patients with abetalipoproteinemia. Atherosclerosis 108, 27-37.
50. Sattler, W., Levak-Frank, S., Radner, H., Kostner, G. M., and Zechner, R. (1996) Muscle-specific overexpression of lipoprotein lipase in transgenic mice results in increased α-tocopherol levels in skeletal muscle. Biochem. J. 318, 15-19.
51. Parks, E. J., Dare, D., Frazier, K. B., Hellerstein, M. K., Neese, R. A., et al. (2000) Dependence of plasma α-tocopherol flux on very low-density triglyceride clearance in humans. Free Radic. Biol. Med. 29, 1151-1159.
52. Minehira-Castelli, K., Leonard, S. W., Walker, Q. M., Traber, M. G., and Young, S. G. (2006) Absence of VLDL secretion does not affect α-tocopherol content in peripheral tissues. J. Lipid Res. 47, 1733-1738.
53. Anwar, K., Iqbal, J., and Hussain, M. M. (2007) Mechanisms involved in vitamin E transport by primary enterocytes and in vivo absorption. J. Lipid. Res. 48, 2028-2038.
54. Dergunov, A. D. and Vorotnikova, I. I. (1993) Interaction of serum albumin with apoprotein E and very low density lipoproteins in human blood. Biokhimiia 58, 944-952.
55. Horiguchi, M., Arita, M., Kaempf-Rotzoll, D. E., Tsujimoto, M., Inoue, K., et al. (2003) pH-dependent translocation of α-tocopherol transfer protein (α-TTP) between hepatic cytosol and late endosomes. Genes Cells 8, 789-800.
56. Arita, M., Nomura, K., Arai, H., and Inoue, K. (1997) α-Tocopherol transfer protein stimulates the secretion of α-tocopherol from a cultured liver cell line through a brefeldin A-insensitive pathway. Proc. Natl. Acad. Sci. USA 94, 12437-12441.
57. Shichiri, M., Takanezawa, Y., Rotzoll, D. E., Yoshida, Y., Kokubu, T., et al. (2010) ATP-binding cassette transporter A1 is involved in hepatic α-tocopherol secretion. J. Nutr. Biochem. 21, 451-456.